2023
DOI: 10.29328/journal.cjog.1001126
|View full text |Cite
|
Sign up to set email alerts
|

Minimally invasive cytoreductive surgery in advanced ovarian cancer: A nonselected consecutive series of robotic-assisted cases

Abstract: The gold standard for advanced-stage ovarian cancer surgery entails exploration via a midline vertical laparotomy. Studies have shown that minimally invasive surgery (MIS) can be a safe and effective method for the surgical management of early ovarian cancer. In some cases, MIS can also be selectively used for cytoreductive surgery in cases with advanced-stage ovarian cancer. The robotic platform has the potential to provide similar outcomes to the laparotomy-based standard of care in advanced complex surgery … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Reports on the use of MIS for primary cytoreduction surgery are fewer compared to interval debulking. In small retrospective series, with careful patient selection, this approach appears to be feasible (13,14). However, there is a lack of data with regard to the oncologic outcome and long term follow up with MIS in the setting of primary debulking for ovarian cancer.…”
mentioning
confidence: 99%
“…Reports on the use of MIS for primary cytoreduction surgery are fewer compared to interval debulking. In small retrospective series, with careful patient selection, this approach appears to be feasible (13,14). However, there is a lack of data with regard to the oncologic outcome and long term follow up with MIS in the setting of primary debulking for ovarian cancer.…”
mentioning
confidence: 99%